MeSH tree: D12.644.548
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have become popular for weight loss, but results vary from person to person and from drug to drug. Venky Soundararajan and colleagues explored the full range of responses ...
Jun 16, 2026
0
16
Exposure to glyphosate, the active ingredient in many weedkillers, was linked to changes in several hormones that support pregnancy and fetal development—in one of the few studies to examine how a widely used herbicide may ...
Jun 16, 2026
0
5
One of the largest real-world studies of people taking GLP-1 medications found women, those without pre-existing conditions such as type 2 diabetes and high blood pressure, and behavioral factors such as previously setting ...
Jun 15, 2026
0
3
Tirzepatide doesn't just help people lose weight; it also activates brown adipose tissue, representing a major milestone in obesity research, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting ...
Jun 15, 2026
0
6
GLP-1 medications are marketed to help you lose weight, but one may be better at it than the rest, according to a new meta-analysis from the University of Georgia.
Jun 15, 2026
0
12
Origami masters turn simple sheets of paper into ornate sculptures. In the origami of life, our cells must fold proteins into specific three-dimensional shapes before they can carry out their biological jobs. This folding ...
Jun 14, 2026
0
12
The Inflation Reduction Act's attempt to improve insulin costs for Medicare beneficiaries—by capping out-of-pocket costs at $35—was associated with lower out-of-pocket costs and increased insulin use, but only for a small ...
Jun 14, 2026
0
3
Researchers at the Monell Chemical Senses Center have found that common dietary sugars fructose and glucose, despite having the same number of calories, communicate with the brain through different gut–brain pathways, a difference ...
Jun 12, 2026
0
46
Gestational diabetes is most commonly associated with temporary disturbances in glucose metabolism during pregnancy. However, growing evidence shows that its consequences may extend far beyond pregnancy itself—affecting a ...
Jun 11, 2026
0
8
A drug called apitegromab may help preserve lean body mass during weight loss with tirzepatide, a GLP-1 receptor agonist, according to a phase 2 clinical trial published in Nature Medicine. The findings suggest that blocking ...
Jun 9, 2026
0
7
